Equally higher levels of miR-21 in CAAs were observed, and miR-21 is transported from CAAs to cancer cells, inhibiting the apoptosis of ovarian cancer cells and producing chemotherapy resistance by combining with its direct new target apoptotic protease activating factor-1 (APAF1) [128]. The gene discussed is APAF1; the disease is ovarian carcinoma.